1–1 of 1 result for Geographic atrophy of the retinal pigment epithelium (GARPE)
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
Updates from the Field
2021